阿摩線上測驗
登入
首頁
>
圖文傳播
>
113年 - 113 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138057
> 申論題
十一、量測黃色的色墨濃度值時,濃度計應選擇何種顏色之濾色鏡?
相關申論題
1.封面紙張每令含稅價格多少元(台幣)?;內頁紙張每令含稅價格多少元(台幣)? (註:運算過程中數字計算位數採四捨五人制,紙張磅數取至小數第1位, 金額取整數。)
#565273
2.封面紙張用量(菊全)多少令?;內頁紙張用量(菊全)多少令? (註:運算過程中數字計算位數採四捨五人制,紙張令數取至小數第1位。)
#565274
3.封面及內頁所需紙張含稅總共需要多少元(台幣)? (註:數字計算位數採四捨五人制,紙張令數取至小數第1位,金額取整數。)
#565275
4.封面及內頁所需製版費用總共需要多少元(台幣)? (註:數字計算位數採四捨五人制,紙張令數取至小數第1位,金額取整數。)
#565276
5.封面及內頁所需印刷費用總共需要多少元(台幣)? (註:數字計算位數採四捨五入制,紙張令數取至小數第1位,金額取整數。)
#565277
6.無線膠裝裝訂費用總共需要多少元(台幣)? (註:數字計算位數採四捨五人制,紙張令數取至小數第1位,金額取整數。)
#565278
7.完成書籍費用總共需要多少元(台幣)? (註:數字計算位數採四舍五人制,紙張令數取至小數第1位,金額取整數)
#565279
I. Please merge the two texts and rewrite them into a short essay of approximately 300 words. Design a 10-option Banked Cloze Test with a difficulty level suitable for 12th-grade studentsat Kaohsiung Girls' Senior High School. Answers must be provided. Passage A: As our daily existence increasingly migrates to the cloud, the management of our digital legacy has surfaced as a painful social dilemma. For grieving families, access to a deceased loved one's socialmedia and cloud storage is far more than a matter of curiosity; it is a vital component of the healing process. In the past, memories were preserved in physical photo albums or handwritten letters. Today,these precious records are locked behind rigid security protocols, leaving families emotionally stranded. Advocates for "digital inheritance" laws argue that these assets should be legally recognized as personal property, passing automatically to the next of kin. Without such protections, technologycompanies act as unintended gatekeepers, often deleting years of family history due to "inactivity."Furthermore, many individuals now store crucial information-ranging from final letters to financialdetails--exclusively in digital formats. To deny family access is to ignore the reality of how one lives and loves in the 21st century. The emotional and practical value of these records demands a radicalshift in the legal definitions of ownership, ensuring that a person's legacy does not expire the moment their heart stops beating. Passage B: The debate over the digital afterlife rests on a fundamental philosophical question: should our online presence be treated as transferable property or as a private, lifelong extension of our personality?While the emotional plea of grieving families is moving, technology companies face a conflicting duty: the absolute preservation of user privacy. A digital account is not merely a modern photo album; it isa vast archive of private interactions, many of which the user may have intended to keep confidential,even from relatives. Granting third-party access even to legal heirs-would set a dangerous precedent that undermines the privacy of encrypted data. Tech firms argue that opening a deceased person's messagescould unintentionally expose the sensitive data of other living individuals who communicated with that user under the assumption of privacy. This would constitute a betrayal of trust. Instead of intrusive laws, the focus should remain on "proactive management." Many platforms now offer tools like "legacy contacts," empowering users to decide the fate of their data long before they pass away. Byutilizing these features, users can exercise their human agency, deciding what to share and what to take to the grave, which effectively protects the privacy of the deceased and their contacts over theemotional comfort of the living.
#565280
II. Please design five reading comprehensive questions based on the passage aligned with the format of the GSAT questions. The questions should test various reading skills, with the firsttwo focusing on identifying the main idea and making inferences. At least three different question types must be included (e.g., multiple-choice, matching, sequencing, fill-in-the-blanks,completion of tables/charts/graphic organizers, or short-answer questions). Please provide an answer key. Recent studies suggest that GLP-1 drugs, originally designed for diabetes and weight loss, mayoffer a groundbreaking approach to treating addiction. A comprehensive study reveals that thesemedications could reduce the risk of developing substance use disorders and minimize the severe consequences of addictive behaviors. The research team, led by Dr. Ziyad Al-Aly, analyzed health records from over 600,000 patients. They compared GLP-1 users with those taking SGLT2 inhibitors. Unlike SGLT2 drugs, whichprimarily affect the kidneys to remove excess sugar, GLP-1 medications target the mesolimbic system in the brain. This region governs reward signals that reinforce cravings for food, alcohol,nicotine, and opioids. By suppressing these signals, GLP-1 drugs effectively "quiet" the brain's desire for addictive substances by suppressing the "food noise" or craving signals that lead todependency. The results were significant. Compared to people prescribed an SGLT2 inhibitor, participants taking GLP-1 drugs showed a 14% to 25% lower risk of developing new addictions. For thosealready struggling with substance abuse, the drugs were associated with a 39% reduction in overdoses and a 50% decrease in drug-related deaths. "There is no precedent in our medical toolkitfor a single medicine that works across such a wide range of addictive substances," Al-Aly noted. Despite these promising findings, experts remain cautious about the long-term implications. One major concern is the "rebound effect." Similar to weight loss patients regaining weight afterstopping the medication, addiction cravings might return "with a vengeance" once the drug is discontinued. Furthermore, it remains unclear whether the brain will develop a tolerance to the treatment over time. Scientists still need to determine the ideal dose and duration required to maintain these benefits safely. While Dr. Al-Aly says that if people qualify for the drugs because they have diabetes or are overweight or obese, and they also want to quit smoking, stop drinking, or control their opioiddependence, then the GLP-1 medications could help. Further research is needed to resolve these uncertainties before GLP-1 can be officially established as a new class of anti-addiction medication. Adapted from: https://time.com/7382492/weight-loss-drugs-prevent-treat-addiction-study/
#565281
(1) Lesson Plan Provide a lesson plan that specifies your teaching objectives, tasks, materials, and assessments.
#565282
相關試卷
114年 - 114 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#137915
114年 · #137915
113年 - 113 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138057
113年 · #138057
112年 - 112 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138242
112年 · #138242
111年 - 111 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138284
111年 · #138284
110年 - 110 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138779
110年 · #138779
109年 - 109 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#138757
109年 · #138757
109年 - 109 中央印製廠_新進人員甄試_印刷技術員、品管技術員:圖文傳播概論#88069
109年 · #88069
108年 - 108 全國高級中等學校學生技藝競賽考試_工業類_圖文傳播科:印刷實務判別#139153
108年 · #139153
108年 - 108 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#139080
108年 · #139080
107年 - 107 全國高級中等學校學生技藝競賽考試_工業類:圖文傳播#139275
107年 · #139275